All stories by SOHINI DAS
Explained: What USFDA full approval to Pfizer-BioNTech vaccine meansRediff.com4 days ago
Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.
Covid Vaccine: Syringe manufacturers are ramping upRediff.com7 days ago
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
Gennova's mRNA vaccine to come in powder form, stay stable at 2-8CRediff.com7 days ago
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.
Govt developing multi-variant Covid-19 vaccineRediff.com7 days ago
Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.
Focus on hospitals as India braces for Covid third waveRediff.com1 Sep 2021
The health system is trying to ensure that it isn't caught by surprise -- the way it was last time. So, hectic preparations are on.
Pharma majors shift focus to inhalants, nasal spray for CovidRediff.com30 Aug 2021
While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.
Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trialsRediff.com25 Aug 2021
If things go according to plan, the vaccine would be available in the market by the end of this year.
Novovax Covid vaccine likely to get nod in India ahead of USRediff.com18 Aug 2021
Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.
Despite nod foreign Covid vaccines likely to be delayed over indemnity clauseRediff.com11 Aug 2021
India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.
Meeting 1.35 bn vax dose target in Aug-Dec a long haulRediff.com6 Aug 2021
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
AstraZeneca finds small clot risk after 1st Covid shotRediff.com29 Jul 2021
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das.
3rd wave: Govt creating 30-day stock of key Covid medicinesRediff.com26 Jul 2021
'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.
Zydus Cadila to begin vaccine trials for kids above 5 yrs soonRediff.com19 Jul 2021
So far, no other vaccine has been approved globally for children below 12 years. Sohini Das reports.
Trade margins capped at 70% for oximeters, BP meters, other medical devicesRediff.com14 Jul 2021
The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.
Serum to double Covid vaccine output in 2022Rediff.com13 Jul 2021
SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million doses a month from 100 million a month now, reports Sohini Das.
Explained: What the Brazil-Covaxin row is aboutRediff.com9 Jul 2021
Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.
India may get 4m doses of Pfizer, Moderna by August from COVAXRediff.com8 Jul 2021
However, before the Moderna and Pfizer messenger ribonucleic acid (or mRNA) vaccines come to India via this route, the legalities around the indemnity clause will have to be settled, reports Sohini Das.
Why Thyrocare sold out to PharmEasyRediff.com5 Jul 2021
'I have done enough work for many years.' 'This is a decision that many people at my age need to review.' 'I may become an exit example for people to study.'
Biological E plans to make 1.5 billion Corbevax jabs in 2021Rediff.com2 Jul 2021
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.
'Covid vaccines are working against new variants'Rediff.com2 Jul 2021
'The key purpose of vaccination is to prevent hospitalisation, severe disease, and death.' 'All vaccines work equally, although mild disease cannot be prevented.'